Zollinger-Ellison syndrome: Difference between revisions
Erdojjones (talk | contribs) |
|||
| Line 1: | Line 1: | ||
==Background== | ==Background== | ||
*Also known as "S-E syndrome" | *Also known as "S-E syndrome" | ||
*gastric | *Caused by secretion of gastrin by duodenal/pancreatic neuroendocrine tumors (gastrinomas) —> high gastric acid output by parietal cells | ||
*Associated with peptic ulcers and diarrhea | *Associated with peptic ulcers and diarrhea | ||
*60% malignant, only 20% resectable; 25% of gastrinoma patients have multiple endocrine neoplasia type I; >80% of gastrinomas found in gastrinoma triangle. | *60-90% malignant <ref> Roy PK, Venzon DJ, Shojamanesh H, Abou-Saif A, Peghini P, Doppman JL, Gibril F, Jensen RT. Zollinger-Ellison syndrome. Clinical presentation in 261 patients. Medicine (Baltimore). 2000 Nov;79(6):379-411. doi: 10.1097/00005792-200011000-00004. PMID: 11144036.</ref>, only 20% resectable; 25% of gastrinoma patients have multiple endocrine neoplasia type I; >80% of gastrinomas found in gastrinoma triangle. | ||
==Clinical Features== | ==Clinical Features== | ||
*Hematemesis | *Hematemesis | ||
*Chronic diarrhea | *Chronic diarrhea that is responsive to PPIs | ||
*[[Gastroesophageal reflux disease]] | |||
*Steatorrhea | *Steatorrhea | ||
*Weight loss | |||
*Postprandial abdominal pain | *Postprandial abdominal pain | ||
*Nausea | *Nausea | ||
| Line 21: | Line 23: | ||
===Diagnosis=== | ===Diagnosis=== | ||
*Fasting serum gastrin concentration (>10x upper limit of normal) in the presence of gastric pH <2 is diagnostic | |||
*If findings not diagnostic for ZES, will require secretin stimulation test | |||
==Management== | ==Management== | ||
Revision as of 06:00, 7 December 2022
Background
- Also known as "S-E syndrome"
- Caused by secretion of gastrin by duodenal/pancreatic neuroendocrine tumors (gastrinomas) —> high gastric acid output by parietal cells
- Associated with peptic ulcers and diarrhea
- 60-90% malignant [1], only 20% resectable; 25% of gastrinoma patients have multiple endocrine neoplasia type I; >80% of gastrinomas found in gastrinoma triangle.
Clinical Features
- Hematemesis
- Chronic diarrhea that is responsive to PPIs
- Gastroesophageal reflux disease
- Steatorrhea
- Weight loss
- Postprandial abdominal pain
- Nausea
- Wheezes on auscultation
- Evidence of malnourishment and decreased oral intake
Differential Diagnosis
Evaluation
Workup
Diagnosis
- Fasting serum gastrin concentration (>10x upper limit of normal) in the presence of gastric pH <2 is diagnostic
- If findings not diagnostic for ZES, will require secretin stimulation test
Management
- Proton-Pump Inhibitors
- Somatostatin analog (Octreotide) if no improvement
- Direct inhibition of gastric secretion
- Surgical resection
Disposition
See Also
External Links
References
- ↑ Roy PK, Venzon DJ, Shojamanesh H, Abou-Saif A, Peghini P, Doppman JL, Gibril F, Jensen RT. Zollinger-Ellison syndrome. Clinical presentation in 261 patients. Medicine (Baltimore). 2000 Nov;79(6):379-411. doi: 10.1097/00005792-200011000-00004. PMID: 11144036.